ArticleFrontiers in oncology2022
Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma.
Anna Soria et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it